Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Molecules containing **iodine** strongly attenuate X-rays through the photoelectric effect and K-edge absorption. The probability of X-ray absorption by an atom is proportional to the cube of its atomic number (\(Z^3\)), making iodine an effective contrast agent in medical imaging due to its high atomic number (53). When introduced into the body as part of iodinated contrast media, these molecules localize in blood vessels or tissues and create regions of high X-ray absorption, increasing the visibility and contrast of anatomical structures on X-ray and CT scans[1][6][7][9]. The attenuation peaks near iodine’s K-edge energy (33.2 keV), which matches the typical photon energies used in diagnostic imaging[5][3]. Iodinated contrast media are primarily used for imaging the vascular system, organs, and soft tissue lesions. Their administration is associated with rare but serious adverse reactions, and they also increase the absorbed radiation dose, raising safety concerns about DNA damage and long-term cancer risk, particularly at higher doses[4][6][8]. This entry does *not* describe a single molecular target, receptor, protein, or enzyme, but rather a *physical property of molecules with covalently bound iodine* used in diagnostic imaging. Therefore, the usual molecular fields do not apply, and the entry is more accurately classified as describing a class of compounds with a particular radiological function.
Increased X-ray attenuation via photoelectric effect and K-edge absorption at diagnostic X-ray energies, primarily due to iodine’s high atomic number (Z = 53) and K-edge (33.2 keV)—results in strongly increased photon absorption versus soft tissue[1][6][7][3][5]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on X-ray attenuation by iodine-containing molecules.